ag-Ip-news

The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Organization
Arabic
Advanced Search
Mailing List Sign Up
Enter your e-mail address to receive daily headlines.

Unsubscribe
Click here for World Law news from NewsNow.co.uk
WAP Service


AGIPNEWS7332

12/7/2009 13:09 GMT
ag-IP-news
Forest and Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco

NEW YORK - Forest Laboratories Inc. and its wholly-owned subsidiary, Forest Laboratories Holdings Ltd., and H. Lundbeck A/S announced that they have entered into a settlement agreement with Sun Pharmaceutical Industries Ltd. and Caraco Pharmaceutical Laboratories Ltd. regarding pending patent infringement disputes.

According to Forest Laboratories, the disputes involve US Patent Re. No. 34,712, US Patent No. 6,916,941, and US Patent No. 7,420,069, which were licensed to Forest by H. Lundbeck A/S on an exclusive basis in the United States.

These patents are listed in the US Food and Drug Administration's Orange Book for Forest's LEXAPRO brand escitalopram oxalate tablet products.

Pursuant to the terms of the settlement agreement with Sun Pharma and Caraco, and subject to review of the settlement terms by the US Federal Trade Commission:

1. Forest and Lundbeck will provide licenses to Caraco for any patents related to LEXAPRO with respect to the marketing of Caraco's generic version of the product as of the date that any third party generic that has properly received final approval from the FDA enters the market, other than an authorized generic or the first filer with Hatch-Waxman related exclusivity.

2. Caraco will take over the commercialization and sale of several products from Forest's Inwood business.

3. In exchange for an upfront payment (and royalties but only if the technology is used), Sun Pharma will license to Lundbeck on a worldwide basis certain patent applications related to the synthesis of escitalopram and citalopram.

Forest and Lundbeck will reimburse certain of Caraco's legal costs in connection with these patent litigations.

Forest Laboratories is a US based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people's lives.


Related Articles
Alnylam Receives Notice of Allowance from USPTO
China IP Offices Close for Spring Festival Holiday
Silicon Laboratories Asserts Intellectual Property Rights
WIPO Pledges Support for Viet Nam
Intellectual Property Will Be Protected, Says Viet Nam President
MOSAID and Samsung Reach Comprehensive Agreement
Fish Rank Tops List for Fortune 100 Companies
Inovio Expands DNA Vaccine IP License with University of Pennsylvania
Computer-Related Inventions Lead in Patent Activity According to Thomson Reuters Report
ClearOne Awarded Attorney Fees and Costs Against Biamp Systems

Top
Go

Home | About Us | How to Use Our Services | Links | Download Our News Ticker | FAQ | What is IP? | Contact Us
Copyright © 2008 ag-IP-news All Rights Reserved
Disclaimer   Terms of Use    Privacy Policy